Microneedles: A novel clinical technology for evaluating skin characteristics
Skin Research and Technology · 2024
DOI: 10.1111/srt.13647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Seo Hyeong Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cutis Biomedical Research Center Co. Ltd., Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Skin Aging, Cosmetics, Pigmentation Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Current methods for evaluating efficacy of cosmetics have limitations because they cannot accurately measure changes in the dermis. Skin sampling using microneedles allows identification of skin‐type biomarkers, monitoring treatment for skin inflammatory diseases, and evaluating efficacy of anti‐aging and anti‐pigmentation products. Materials and methods Two studies were conducted: First, 20 participants received anti‐aging treatment; second, 20 participants received anti‐pigmentation treatment. Non‐invasive devices measured skin aging (using high‐resolution 3D‐imaging in the anti‐aging study) or pigmentation (using spectrophotometry in the anti‐pigmentation study) at weeks 0 and 4, and adverse skin reactions were monitored. Skin samples were collected with biocompatible microneedle patches. Changes in expression of biomarkers for skin aging and pigmentation were analyzed using qRT‐PCR.
Results
No adverse events were reported. In the anti‐aging study, after 4 weeks, skin roughness significantly improved in 17 out of 20 participants. qRT‐PCR showed significantly increased expression of skin‐aging related biomarkers: PINK1 in 16/20 participants, COL1A1 in 17/20 participants, and MSN in 16/20 participants. In the anti‐pigmentation study, after 4 weeks, skin lightness significantly improved in 16/20 participants. qRT‐PCR showed significantly increased expression of skin‐pigmentation‐related biomarkers: SOD1 in 15/20 participants and Vitamin D Receptor (VDR) in 15/20 participants. No significant change in TFAP2A was observed.
Conclusion
Skin sampling and mRNA analysis for biomarkers provides a novel, objective, quantitative method for measuring changes in the dermis and evaluating the efficacy of cosmetics. This approach complements existing evaluation methods and has potential application in assessing the effectiveness of medical devices, medications, cosmeceuticals, healthy foods, and beauty devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cutis Biomedical Research Center Co. Ltd., Seoul, Republic of Korea.
- Yonsei BB Skin Clinic, Seoul, Republic of Korea.
- Raphas Co. Ltd., Seoul, Republic of Korea.
Zitieren
APA
Kim, S. H., Kim, J. H., Choi, Y. M., Seo, S. M., Jang, E. Y., Lee, S. J., Cho, S., Jeong, D. H., & Lee, K. H. (2024). Microneedles: A novel clinical technology for evaluating skin characteristics. Skin Research and Technology. https://doi.org/10.1111/srt.13647
Vancouver
Kim SH, Kim JH, Choi YM, Seo SM, Jang EY, Lee SJ, et al. Microneedles: A novel clinical technology for evaluating skin characteristics. Skin Research and Technology. 2024. doi:10.1111/srt.13647
BibTeX
@article{Kim2024,
author = {Kim, Seo Hyeong and Kim, Ji Hye and Choi, Yoon Mi and Seo, Su Min and Jang, Eun Young and Lee, Sung Jae and Cho, Suhyun and Jeong, Do Hyeon and Lee, Kwang Hoon},
title = {Microneedles: A novel clinical technology for evaluating skin characteristics},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13647}
}
EUVIMED